The invention relates to compounds (I) wherein the variables are as defined in the specification. They inhibit the binding of the SDF-1 chemokine or I-TAC to the chemokine receptor CCXCKR2 and are useful in preventing tumor cell proliferation, tumor formation, and metastasis.